Detailed price information for Akero Therapeutics Inc (AKRO-Q) from The Globe and Mail including charting and trades.

The Japanese benchmark Nikkei 225 slipped 335 points or 0.88 percent to close at 37,793.00. The day's trading range was between 37,621 and 37,863.5. Taiyo Yuden gained 6.8 percent followed by Aozora ...

Click the link below to download a spreadsheet with an example Revenue calculation for Sumitomo Dainippon Pharma Co Ltd below: The chart above depicts the distribution of Revenue for companies ...

Sumitomo Dainippon Pharma Co ( (DNPUF)) has released its Q2 earnings. Here is a breakdown of the information Sumitomo Dainippon Pharma Co presented to its investors. Sumitomo Dainippon Pharma Co ...

100% of client accounts are long on this market The percentage of IG client accounts with positions in this market that are currently long or short. Calculated to the nearest 1%.

Article ‘Count’ and ‘Share’ for Sumitomo Dainippon Pharma Drug Development Research Laboratories based on listed parameters only. According to the parameters selected above, there are no ...

Sumitovant Biopharma Ltd., in partnership with its parent company Sumitomo Dainippon Pharma Co., Ltd., recently announced the launch of a phase 1 study in the U.S. on a new drug candidate (“KSP ...

Sumitomo Dainippon Pharma Co. Ltd., its U.S.-based subsidiary Sunovion Pharmaceuticals Inc. and Otsuka Pharmaceutical Co. Ltd. have inked a global collaboration agreement to jointly advance four new ...

OSAKA, Japan & TOKYO, Japan--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion),its parent company Sumitomo Dainippon Pharma Co., Ltd. (Sumitomo Dainippon Pharma) and Otsuka Pharmaceutical ...

Officials at Cytonome say the company assisted Japanese pharmaceutical firm Sumitomo Dainippon Pharma in producing enough human stem cells to proceed with a clinical trial of a new treatment aimed ...

Osaka-based Sumitomo Dainippon Pharma plans to begin the American trials in fiscal 2022. The goal is to produce a cell transplant treatment that improves the condition of patients with Parkinson's ...